BenevolentAI Unaudited Preliminary Results for the Year Ended 31 December 2023
Focused on delivering cutting edge AI-driven drug discoveryLONDON--(BUSINESS WIRE)--Regulatory News: BenevolentAI (“BenevolentAI”, “the Company” or “the Group”) (Euronext Amsterdam: BAI), ...